BCAL to Acquire Shares in Genetic Signatures
Filed with ASX · · 2 pages · English
BCAL Diagnostics Limited on 6ix
Earlier from BCAL Diagnostics
- BCAL Secures Funding for FY2027
- BCAL Develops New Blood Test for Breast Cancer Recurrence
- BCAL Launches Early Detection Cancer Platform
- BCAL Appoints Anne-Louise Arnett as Chief Executive Officer
- BCAL Accelerates Rollout of Avantect Early Detection Tests
Later from BCAL Diagnostics
- Quarterly Activities/Appendix 4C Cash Flow Report
- Bioshares Conference Investor Presentation
- Proposed issue of securities - BDX
- Notification regarding unquoted securities - BDX
- BCAL Secures Funding for FY2027 Update
Follow BCAL Diagnostics into a list and get an email when it puts out news.
Follow BCAL Diagnostics